This new drug, which treats a rare disease, isn't expensive to produce; even with the unique treatment process, the total cost wouldn't exceed 20,000 yuan. The reason it's so expensive is primarily due to the high R&D costs. A four billion yuan investment has to pay off, and pharmaceutical companies develop drugs to make money, so they need to make a profit.
Since the drug was so expensive, it was destined to be unaffordable for most people. Therefore, neither the initial consideration of recovering investment nor profit was considered. As long as 2,000 courses of new drug were sold within the 20-year patent period, the investment would be recovered; the rest would be profit. With so many patients worldwide, this would be easy to recover.
Si Mingyu has established a charity fund, which seemingly provides each impoverished patient with subsidies ranging from 1.7 million to 2 million yuan. While the foundation has already spent over a billion yuan, that's just on paper. The money simply flows from the charity fund to the pharmaceutical company, with each patient actually spending only 20,000 yuan. Furthermore, the government also includes taxes and fees on this portion of the funds, so the actual expenditure is even lower.
So even if there were 100,000 patients in China, and the charity provided free treatment for all of them, the total cost would only be 2 billion. For Si Mingyu, this was only half a month's net income, and this was after deducting all the costs including food, clothing, housing, transportation, and company operations.
Just think about it, if you live frugally and only spend 50 million a day, you can help 100,000 people in a month. What a great sense of accomplishment that would be.
This interview program caused a huge social response as soon as it was broadcast on Shanghai TV, and platforms such as Penguin, Character, and Coin Station also reprinted it at the instruction of their own bosses, and it received overwhelming praise both online and offline.
Si Mingyu's phrase, "It's only 100 billion, is that a lot?" became a trending online phrase and a new meme of the year. It was even hailed by netizens as "the most popular way to flaunt wealth."
Lian Pipi Tuan also forwarded this message and left a message: "Please increase your efforts to show off your wealth. I also hope that more people will join the ranks of showing off your wealth."
Live streamer Xu Kexin did a live broadcast of the treatment of patients at the designated Shanghai Jiaotong University Affiliated Hospital. By that day, 37 patients had been admitted, both from Shanghai and surrounding cities. Xu Kexin interviewed 23 of these patients or their families, all of whom received assistance from the charity fund. Twenty-one of them received 2 million yuan, equivalent to free treatment, and one received 1.9 million yuan.
The maximum number of online viewers for Xu Kexin's live broadcast was close to 80,000, and the post-edited version was viewed over one million times.
In addition to her, there are other online self-media people who have interviewed designated treatment hospitals and patients, and the results have confirmed without exception that all eligible patients have received assistance.
Netizens left messages in the live broadcast room and under the video:
"He does more than he says, and devotes himself to charity. I like Si Mingyu." This netizen's child should be quite old.
"The greatest joy of doing charity is that all patients have been cured but the charity funds have not been spent." This netizen clearly revealed his age.
"After watching the interview, I immediately printed out Si Mingyu's photo and placed it on my desk to remind me to be kind. Do you think I did the right thing? Just to add, I'm a woman." The most-liked reply to her post was: "You just covet his good looks and his body."
"I am a patient with a certain type of rare disease. I am grateful for the help from Mr. Si Mingyu and the East Asia Mingyu Charity Foundation. Now I have entered the recovery period." Below this post are rows of blessings such as "I wish you good health" and "I hope you will get well soon."
Interestingly, as the post went viral, many female netizens began to spontaneously "claim him as their husband." After all, Si Mingyu is really handsome, has a great temperament, and is also really rich.
Considering that even popular young celebrities can easily attract millions of fans, it's no surprise that Si Mingyu, who is equally handsome and wealthy, is treated this way. The biggest plus point is that he's genuinely good to Zhang Ningxi. Female netizens, putting themselves in his shoes, feel that he's the perfect husband.
Of course, many people on the Internet can see the problem with Si Mingyu's "selling and buying by himself" operation. Some people also made videos and posted articles to prove that the actual cost is not as exaggerated as 100 billion Chinese yuan, but these people are just taking the opportunity to ride on the popularity and show off their relevant knowledge.
Even they had to admit that without this charitable fund, which indirectly reduced drug costs, most people wouldn't have received treatment, or wouldn't have received it so early. Furthermore, the number of people being helped was significant, and with such a large base, even if the per capita expenditure was low, the actual expenditure of the East Asia Mingyu Charity Fund would still exceed 2 billion Chinese yuan.
Two billion Chinese yuan is a considerable sum in the charity field. You should know that although many people donated amounts far greater than this figure, most of them were in the form of equity donations, while Si Mingyu's East Asia Mingyu Charity Foundation spent real money on patients.
When the news spread abroad, even though some foreign media with ulterior motives slandered Si Mingyu, most foreign media and foreign netizens could not find any problems with him.
The price is unified globally. Although this drug has a small audience, Dongya Mingyu Pharmaceutical Company has made a great effort.
As for the charitable foundation, it's Si Mingyu who's willing to pay for it. If the media or the public in any country have any concerns, they can contact their own country's representatives. Doesn't your Fifty State Federation have a plethora of charitable foundations? They can go to them.
Therefore, it makes sense to sell the medicine first and then provide subsidies. At least there is no problem from the perspective of legal rules.
Of course, in foreign media, this matter has only attracted great attention from some rare disease patient organizations, but in fact not many countries and media have reported on it.
It's just that a few foreign media outlets with ulterior motives distorted the facts in their reports in order to discredit Si Mingyu, so ordinary people will just read it and forget about it, and the matter will soon be over.
Then came another piece of news.
Dongya Mingyu Group Co., Ltd. and Shanghai Jiaotong University jointly established a project team for research on a certain type of rare disease drug, with Si Mingyu providing the funding and Shanghai Jiaotong University providing some of the researchers.
If the drug is successfully developed, the patent will belong to the East Asia Mingyu Group, but Si Mingyu promised to continue to provide relief services to Chinese patients in the form of this foundation.
In fact, the medical tutor at Jiaotong University is just a figurehead, and most of the work is still done by Li Zhenyuan’s Medical Research Institute.
This is equivalent to giving Jiaotong University and these tutors a good reputation for free.
Patients suffering from this rare disease have begun to pray for successful research and development every day.
Continue read on readnovelmtl.com
